Substance
ELEXACAFTOR
Global reference: every product and company linked to this substance.
- cas: 2216712-66-0
- ncit: C169935
- pubchem_cid: 134587348
- rxnorm: 2256951
- unii: RRN67GMB0V
3-PYRIDINECARBOXAMIDE, N-((1,3-DIMETHYL-1H-PYRAZOL-4-YL)SULFONYL)-6-(3-(3,3,3-TRIFLUORO-2,2-DIMETHYLPROPOXY)-1H-PYRAZOL-1-YL)-2-((4S)-2,2,4-TRIMETHYL-1-PYRROLIDINYL)- · elexacaftor [INN] · ELEXACAFTOR [USAN] · Elexacaftor [WHO-DD] · TRIKAFTA COMPONENT ELEXACAFTOR · VX-445
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK | TRIKAFTA (COPACKAGED) | Q2 2026 | $2.5B* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- TRIKAFTA (COPACKAGED) · VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK